Harpagin tablets are a combination medication used primarily to treat gout and high blood uric acid levels. These tablets contain two active ingredients: allopurinol 100 mg and benzbromarone 20 mg. This combination helps reduce the formation of urate crystals that cause gout attacks and their associated damage.
What are the ingredients in Harpagin?
Harpagin tablets contain the following active ingredients:
Allopurinol: 100 mg.
Benzbromarone: 20 mg.
The tablets also contain inactive ingredients.
Indications for Use
Harpagin tablets are used to treat:
Chronic gout: to prevent acute gout attacks and reduce their recurrence.
Hyperuricemia: when uric acid levels in the blood are persistently high and require medical intervention. Conditions in which uric acid stones form in the kidneys.
Nodular gout: where urate crystals accumulate in the joints and soft tissues.
Treatment aims to lower blood uric acid levels to normal, prevent urate crystal formation, and thus reduce gout attacks and associated complications.
What is the dosage of Harpagin?
Harpagin tablets should be taken as directed by your doctor. The dosage and duration of treatment are determined based on blood uric acid levels and the patient's response.
The usual adult dosage is one tablet daily. The dosage may be adjusted based on uric acid levels.
Swallow the tablet whole with a large glass of water. It is preferable to take the medication after meals to reduce any potential gastrointestinal disturbances. It is very important to drink adequate amounts of water (2-3 liters daily) during treatment to help prevent kidney stones. It is important to adhere to the prescribed dosage and duration of treatment as determined by your doctor.
What are the side effects of Harpagin?
Harpagin tablets may cause some side effects, some of which are common and others can be serious:
Common side effects:
Gastrointestinal disturbances: nausea, vomiting, diarrhea.
Skin rash (may be mild or severe).
Headache.
What are the contraindications for using Harpagin?
Harpagin tablets are contraindicated in the following cases:
Hypersensitivity to allopurinol, benzbromarone, or any of the other ingredients of the medicine.
Severe or acute kidney failure.
Severe liver failure.
Pregnancy and breastfeeding.
Children under 18 years of age.
In acute gout attacks (treatment should be initiated after the acute attack has been controlled).
Harpagen should be used with extreme caution in patients with kidney problems (dose adjustment may be required) or a history of liver disease. The doctor should be informed of all existing medical conditions and all medications being taken (including herbal supplements) before starting this medicine.